N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide

C17H17N3O3 — CID 110707136

IUPACN-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide
SMILESO=C(NCCN1CC(c2ccccc2)OC1=O)c1ccncc1
InChIInChI=1S/C17H17N3O3/c21-16(14-6-8-18-9-7-14)19-10-11-20-12-15(23-17(20)22)13-4-2-1-3-5-13/h1-9,15H,10-12H2,(H,19,21)
InChIKeyRLSLEVNHTBXMJJ-UHFFFAOYSA-N
MW311.34 g/mol
LogP2.00
Rot. Bonds5

About N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide

N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide (PubChem CID 110707136) has the molecular formula C17H17N3O3 and a molecular weight of 311.34 g/mol. Its IUPAC name is N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide.

Molecular Properties

Compound NameN-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide
PubChem CID110707136
Molecular FormulaC17H17N3O3
Molecular Weight311.34 g/mol
Exact Mass311.13
IUPAC NameN-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide
SMILESO=C(NCCN1CC(c2ccccc2)OC1=O)c1ccncc1
InChIInChI=1S/C17H17N3O3/c21-16(14-6-8-18-9-7-14)19-10-11-20-12-15(23-17(20)22)13-4-2-1-3-5-13/h1-9,15H,10-12H2,(H,19,21)
InChIKeyRLSLEVNHTBXMJJ-UHFFFAOYSA-N
XLogP2.00
TPSA71.53 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500311.34
LogP ≤ 52.00
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-chloro-N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]benzamide
CID 110707134
N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]thiophene-2-carboxamide
CID 110707115
6-oxo-N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]-4,5-dihydro-1H-pyridazine-3-carboxamide
CID 110741013
N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]butanamide
CID 110707104
(3R)-5-oxo-1-[2-(pyridine-4-carbonylamino)ethyl]pyrrolidine-3-carboxylic acid
CID 95121214
N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]benzenesulfonamide
CID 110707155
N-[(3-methyl-2-oxo-1,3-oxazolidin-5-yl)methyl]pyridine-4-carboxamide
CID 110710356
N-[3-[(2R,6R)-2,6-dimethylmorpholin-4-yl]propyl]pyridine-4-carboxamide
CID 51725583
3-(2-aminoethyl)-5-pyridin-3-yl-1,3-oxazolidin-2-one
CID 82077424
N-[(3S,7R,8aS)-3-phenyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-7-yl]pyridine-4-carboxamide
CID 154820381
N-benzylpyridine-4-carboxamide;hydrochloride
CID 110755427
N-[2-(2,3-dioxo-4H-quinoxalin-1-yl)ethyl]pyridine-4-carboxamide
CID 110396450

Frequently Asked Questions

What is the IUPAC name of N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide?
The IUPAC name of N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide (CID 110707136) is N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide.
What is the SMILES notation for N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide?
The canonical SMILES for N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide is O=C(NCCN1CC(c2ccccc2)OC1=O)c1ccncc1.
What is the InChIKey of N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide?
The InChIKey is RLSLEVNHTBXMJJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H17N3O3/c21-16(14-6-8-18-9-7-14)19-10-11-20-12-15(23-17(20)22)13-4-2-1-3-5-13/h1-9,15H,10-12H2,(H,19,21).
What are the key properties of N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide?
N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide has a molecular weight of 311.34 g/mol, XLogP of 2.00, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(2-oxo-5-phenyl-1,3-oxazolidin-3-yl)ethyl]pyridine-4-carboxamide is sourced from PubChem (CID 110707136), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).